New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning-Reference-Cited by-同舟云学术

New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning

Published:2020-07-24 Issue:10 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Poinsignon Vianney¹^ORCID,Faivre Laura²,Nguyen Laurent³,Neven Benedicte⁴,Broutin Sophie¹,Moshous Despina⁴,Bourget Philippe⁵,Dufour Christelle⁶,Dalle Jean‐Hugues⁷,Galambrun Claire⁸,Devictor Benedicte⁹,Kemmel Veronique¹⁰,De Berranger Eva¹¹,Gandemer Virginie¹²,Vannier Jean Pierre¹³,Jubert Charlotte¹⁴,Bondu Sabrina¹,Mir Olivier¹,Petain Aurelie³,Vassal Gilles¹⁵,Paci Angelo¹¹⁶^ORCID

Affiliation:

1. Département de Biologie et Pathologie Médicale, Service de Pharmacologie Gustave Roussy Villejuif France

2. Département de Biostatistiques Gustave Roussy Villejuif France

3. Clinical Pharmacokinetics Department Pierre Fabre Research Institute Toulouse France

4. Pediatric Immunology and Hematology Department Hôpital Necker Enfants‐Malades Paris France

5. Pharmacy Department Hôpital Necker Enfants‐Malades Paris France

6. Département de Cancérologie de l'enfant et l'adolescent Gustave Roussy Villejuif France

7. Hemato‐immunology Department Robert Debré Hospital Paris France

8. Department of Pediatric Hematology La Timone Hospital Marseille France

9. Pharmacy Department La Timone Hospital Marseille France

10. Biology Department Strasbourg Universitary Hospital Strasbourg France

11. Department of Pediatrics University Children's Hospital Lille France

12. Department of Paediatric Haematology/Oncology University Hospital of Rennes Rennes France

13. Paediatric Oncology and Haematology Unit Charles Nicolle Rouen University Hospital Rouen France

14. Department of Pediatric Oncology and Hematology Hôpital Pellegrin Bordeaux France

15. Direction de la Recherche Gustave Roussy Villejuif France

16. Université Paris‐Saclay School of Pharmacy F‐92296 Chatenay‐Malabry France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28603

Reference35 articles.

1. Busulfan bioavailability

2. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

3. Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders;Hassan M;Bone Marrow Transplant,1996

4. Graft‐rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics;Slattery JT;Bone Marrow Transplant,1995

5. Association of busulfan area under the curve with veno‐occlusive disease following BMT;Dix SP;Bone Marrow Transplant,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Model-Informed Precision Dosing of Intravenous Busulfan in Thai Pediatrics Undergoing Hematopoietic Stem Cell Transplantation;Therapeutic Drug Monitoring;2024-05-14

3. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations;Clinical Pharmacokinetics;2023-07

4. Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01

5. Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance;CPT: Pharmacometrics & Systems Pharmacology;2022-06-16